𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Physical capacity in women with primary Sjögren's syndrome: A controlled study

✍ Scribed by Strömbeck, Britta ;Ekdahl, Charlotte ;Manthorpe, Rolf ;Jacobsson, Lennart T. H.


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
90 KB
Volume
49
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Objective

To examine physical capacity (aerobic capacity, joint mobility, muscle function, and standing balance) in women with primary Sjögren's syndrome (primary SS) and to examine the correlation of aerobic capacity with fatigue, functional disability, and mental aspects (anxiety and depression).

Methods

Fifty‐one women who fulfilled the European Community criteria for primary SS and who had anti‐SSA/SSB antibodies or a positive lip biopsy were compared with 51 age‐matched controls. Physical capacity, fatigue, functional disability, anxiety, and depression were investigated by means of questionnaires and clinical examinations.

Results

The women with primary SS had significantly decreased aerobic capacity (VO~2max~ = 28.7 versus 32.4 ml/kg/minute; P = 0.013), shoulder mobility (58 versus 59 scale points; P = 0.003), grip strength (214 versus 259 N; P = 0.000), isokinetic strength of the knee flexors (51 versus 56 Nm; P = 0.049), endurance of the knee flexors (620 versus 712 J; P = 0.008), and standing balance (25 versus 28 seconds; P = 0.006) when compared with the reference group. For the primary SS patients, greater effort was needed to carry out the test of aerobic capacity, and they experienced more pain during the shoulder mobility test. Aerobic capacity correlated with the fatigue experienced (r = –0.33, P = 0.022) but not with functional disability or mental aspects.

Conclusion

The results indicate that women with primary SS have decreased physical capacity, which may be related to the experience of fatigue.


📜 SIMILAR VOLUMES


Inefficacy of infliximab in primary Sjög
✍ Xavier Mariette; Philippe Ravaud; Serge Steinfeld; Gabriel Baron; Joelle Goetz; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

## Objective: There is no effective treatment for patients with primary sjögren's syndrome (ss). since tumor necrosis factor alpha (tnf alpha) could be a key element in the pathogenesis of primary ss, we conducted a multicenter, randomized, double-blind, placebo-controlled trial to evaluate the eff